Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 6/20 | 0.42 |
| ▸ | TYMP | P19971 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | ALB | P02768 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8903799 | 0.91 | TK1 (0.42) | TK1LMNAALBBLMALDH1A1 | |
| SCHEMBL6322837 | 0.85 | TK1 (0.38) | TK1LMNAALBBLMALDH1A1 | |
| SCHEMBL31627956 | 0.84 | TK1 (0.43) | TK1LMNAALBBLMALDH1A1 | |
| SCHEMBL29364921 | 0.83 | TK1 (0.45) | TK1LMNAALBBLMALDH1A1 | |
| SCHEMBL547924 | 0.83 | TK1 (0.43) | TK1LMNAALBBLMTSHR | |
| SCHEMBL8727960 | 0.83 | TK1 (0.43) | TK1LMNAALBBLMTSHR | |
| SCHEMBL4809531 | 0.82 | TK1 (0.44) | TK1LMNAALBBLMALDH1A1 | |
| SCHEMBL135210 | 0.82 | TK1 (0.44) | TK1LMNAALBBLMALDH1A1 | |
| SCHEMBL16187026 | 0.82 | TK1 (0.44) | TK1LMNAALBBLMALDH1A1 | |
| SCHEMBL8438314 | 0.81 | TK1 (0.43) | TK1LMNAALBBLMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115926568-B | Resin film formed of cell culture scaffold material, cell culture carrier, and cell culture container | 积水化学工业株式会社 | 2025-05-09 | — | — | CN | disclosed |
| EP-0737201-A4 | BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS AND SOLID PHASE SYNTHESIS THEREOF | ISIS PHARMACEUTICALS INC (US) | 1998-12-30 | — | — | EP | disclosed |
| US-5677439-A | PREVENTION GENE EXPRESSION | SANOFI (FR) | 1997-10-14 | — | — | US | disclosed |
| EP-0753002-A1 | MODIFIED OLIGONUCLEOTIDES AND INTERMEDIATES USEFUL IN NUCLEIC ACID THERAPEUTICS | AMGEN INC. (US) | 1997-01-15 | — | — | EP | disclosed |
| EP-0737201-A1 | BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS AND SOLID PHASE SYNTHESIS THEREOF | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-16 | — | — | EP | disclosed |
| EP-0541722-B1 | COMPOUNDS AND METHODS FOR INHIBITING GENE EXPRESSION | STERLING WINTHROP INC (US) | 1995-12-20 | — | — | EP | disclosed |
| WO-1995026972-A1 | MODIFIED OLIGONUCLEOTIDES AND INTERMEDIATES USEFUL IN NUCLEIC ACID THERAPEUTICS | AMGEN INC. (US) | 1995-10-12 | — | — | WO | disclosed |
| WO-1995018136-A1 | BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS AND SOLID PHASE SYNTHESIS THEREOF | ISIS PHARMACEUTICALS, INC. (US) | 1995-07-06 | — | — | WO | disclosed |
| EP-0541722-A1 | COMPOUNDS AND METHODS FOR INHIBITING GENE EXPRESSION. | STERLING WINTHROP INC (US) | 1993-05-19 | — | — | EP | disclosed |
| WO-1992002534-A2 | COMPOUNDS AND METHODS FOR INHIBITING GENE EXPRESSION | STERLING DRUG, INC. (US) | 1992-02-20 | — | — | WO | disclosed |